Related Experiment Video
Updated: Jun 27, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
MEFV gene 3'-UTR Alu repeat polymorphisms in patients with familial Mediterranean fever
1Department of Genetics, Institute for Experimental Medicine, Istanbul Faculty of Medicine, Istanbul, Turkey.
Objective:
Familial Mediterranean fever (FMF), an autosomal recessively inherited autoinflammatory disorder, is caused by missense mutations in the pyrin-encoding MEFV gene. The MEFV mutations can be detected in the majority of FMF patients, but there is an important proportion of patients with the FMF phenotype who carry a single or no coding region mutation. This study aimed to investigate the promoter region and 3'-UTR polymorphisms of the MEFV gene in a group of FMF patients with no coding region mutations, to identify variations with a possible role in the regulation of MEFV expression.
Methods:
The study group consisted of 289 patients with FMF and 103 ethnically-matched healthy individuals of Turkish origin. All individuals were first genotyped for the five most commonly observed mutations (M694V, M680I, V726A, E148Q and M694I). Then, the coding regions of the MEFV gene in patients carrying none of the 5 mutations were amplified and screened using single-stranded conformation polymorphism and DNA sequencing. After the exclusion of patients with mutations in exons, the promoter and 3'-UTR regions of the MEFV gene were investigated in the remainder. For the haplotype analysis, all study groups were genotyped for two of the 3'-UTR single nucleotide polymorphisms (SNP).
Results:
Genotyping for five mutations revealed 186 patients (64.4%) with two mutations, 61 patients (21.1%) with one mutation, and 42 patients (14.5%) with no mutation. The carrier rate for healthy controls was found to be 10%. After screening all 10 exons in the patients with none of the 5 mutations, we identified 36 patients (12.5%) who had no coding region mutations. Analysis of the 3'-UTR region in these patients showed two Alu repeats (AluSx and AluSq), which were located in the 3'-UTR of the reference mRNA sequence. Sequencing of the 3'-UTR of the MEFV gene showed several SNPs that were clustered in 2 haplotypes. When we genotyped all study groups for two of the 3'-UTR SNPs (rs2741918 and rs450021), we observed a significant increase in the frequency of heterozygotes for the 3'-UTR haplotypes in the FMF patients with no coding region polymorphisms compared to the healthy controls (75% versus 48.5%, p=0.006, OR=3.2, 95% CI 1.4-7.4).
Conclusion:
This study showed a group of 3'-UTR polymorphisms in the MEFV gene that are clustered in two haplotypes. In addition, a genetic association was observed between 3'-UTR polymorphisms and the FMF patients with no coding region mutations. These findings may suggest a role for 3'-UTR sequences in the regulation of MEFV expression.
Insights
Familial Mediterranean fever (FMF) is linked to MEFV gene variations. This study found 3'-UTR polymorphisms associated with FMF in patients lacking coding region mutations, suggesting a role in gene expression regulation.
Area of Science:
- Genetics
- Molecular Biology
- Immunology
Background:
- Familial Mediterranean fever (FMF) is an autoinflammatory disorder inherited in an autosomal recessive pattern.
- It is caused by mutations in the pyrin-encoding MEFV gene, detectable in most FMF patients.
- However, a subset of FMF patients exhibits the phenotype without detectable coding region mutations.
Purpose of the Study:
- To investigate promoter and 3 -UTR polymorphisms of the MEFV gene.
- To identify variations in FMF patients with no coding region mutations.
- To explore the potential role of these variations in regulating MEFV gene expression.
Main Methods:
- Genotyping of 289 FMF patients and 103 healthy controls for common MEFV mutations.
- Screening of MEFV coding regions in mutation-negative patients using single-stranded conformation polymorphism and DNA sequencing.
- Analysis of MEFV promoter and 3 -UTR regions, including haplotype analysis of 3 -UTR single nucleotide polymorphisms (SNPs).
Main Results:
- 14.5% of FMF patients had no detectable mutations among the five common ones.
- 36 patients (12.5%) lacked any identified coding region mutations.
- A significant association was found between 3 -UTR polymorphisms (in two haplotypes) and FMF patients with no coding region mutations (75% vs. 48.5%, p=0.006).
Conclusions:
- The study identified MEFV 3 -UTR polymorphisms clustered in two haplotypes.
- A genetic association exists between these 3 -UTR polymorphisms and FMF patients lacking coding region mutations.
- These findings suggest that 3 -UTR sequences may play a role in regulating MEFV gene expression.
More Related Videos
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
07:24Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Non-LTR Retrotransposons
Master Transcription Regulators
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu